Nancy A Simonian Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy A Simonian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy A Simonian. Nancy A Simonian is Director in ARQULE INC ($ARQL) and Director in SEATTLE GENETICS INC /WA ($SGEN) and President & CEO in Syros Pharmaceuticals, Inc. ($SYRS) and President and CEO in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Evelo Biosciences, Inc. ($EVLO).
Latest Insider Trading Transactions of Nancy A Simonian
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARQL, EVLO, SGEN, SYRS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 11.41 | 304,000 | 3,468,640 | 304,000 | |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 10.09 | 4,988 | 50,329 | 280,012 | |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 8.51 | 14,168 | 120,570 | 79,165 | |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 10,761 | 32,713 | 21,524 | |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 10.09 | 4,988 | 50,329 | 563,606 | 558.6 K to 563.6 K (+0.89 %) |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 8.51 | 14,168 | 120,570 | 558,618 | 544.5 K to 558.6 K (+2.60 %) |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 10,761 | 32,713 | 544,450 | 533.7 K to 544.5 K (+2.02 %) |
| Jun 18 2020 | EVLO | Evelo Biosciences, ... | Simonian Nancy A | Director | Option Exercise | A | 3.59 | 15,690 | 56,327 | 15,690 | |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 1,335 | 0 | 26,098 | 24.8 K to 26.1 K (+5.39 %) |
| Feb 14 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 7.54 | 294,000 | 2,216,760 | 294,000 | |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 8,210 | 24,958 | 1,018,123 | |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 10,762 | 32,716 | 1,026,333 | |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 33,429 | 101,624 | 1,037,095 | |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 52,401 | 159,299 | 533,689 | 481.3 K to 533.7 K (+10.89 %) |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 8,210 | 24,958 | 1,018,123 | |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 10,762 | 32,716 | 1,026,333 | |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 33,429 | 101,624 | 1,037,095 | |
| Dec 23 2019 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 52,401 | 159,299 | 533,689 | 481.3 K to 533.7 K (+10.89 %) |
| Jun 13 2019 | EVLO | Evelo Biosciences, ... | Simonian Nancy A | Director | Option Exercise | A | 7.07 | 15,690 | 110,928 | 15,690 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 2,963 | 0 | 24,763 | 21.8 K to 24.8 K (+13.59 %) |
| Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 12,084 | 36,735 | 785,523 | |
| Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 1.01 | 75,050 | 75,801 | 797,607 | |
| Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 1.01 | 23,454 | 23,689 | 872,657 | |
| Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 3.04 | 12,084 | 36,735 | 481,288 | 469.2 K to 481.3 K (+2.58 %) |
| Dec 03 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 1.01 | 98,504 | 99,489 | 469,204 | 370.7 K to 469.2 K (+26.57 %) |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 3,700 | 0 | 21,800 | 18.1 K to 21.8 K (+20.44 %) |
| May 10 2018 | EVLO | Evelo Biosciences, ... | Simonian Nancy A | Director | Option Exercise | A | 16.00 | 31,380 | 502,080 | 31,380 | |
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 10.09 | 285,000 | 2,875,650 | 285,000 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 3,700 | 0 | 18,100 | 14.4 K to 18.1 K (+25.69 %) |
| Feb 13 2017 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 10.90 | 175,000 | 1,907,500 | 175,000 | |
| Sep 19 2016 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 12.17 | 75,000 | 912,750 | 75,000 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President and CEO | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President and CEO | Buy | C | 0.00 | 66,666 | 0 | 370,702 | 304 K to 370.7 K (+21.93 %) |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 3,700 | 0 | 14,400 | 10.7 K to 14.4 K (+34.58 %) |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 3,700 | 0 | 10,700 | 7 K to 10.7 K (+52.86 %) |
| May 17 2010 | ARQL | ARQULE INC | Simonian Nancy A | Director | Option Exercise | A | 6.14 | 15,000 | 92,100 | 65,000 | |
| May 18 2009 | ARQL | ARQULE INC | Simonian Nancy A | Director | Option Exercise | A | 3.87 | 10,000 | 38,700 | 50,000 | |
| May 19 2008 | ARQL | ARQULE INC | Simonian Nancy A | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 40,000 | |
| May 22 2007 | ARQL | ARQULE INC | Simonian Nancy A | Director | Option Exercise | A | 9.02 | 10,000 | 90,200 | 30,000 | |
| May 22 2006 | ARQL | ARQULE INC | Simonian Nancy A | Director | Option Exercise | A | 5.30 | 10,000 | 53,000 | 20,000 | |
| May 15 2006 | ARQL | ARQULE INC | Simonian Nancy A | Director | Option Exercise | A | 5.68 | 10,000 | 56,800 | 10,000 |
Page: 1